Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $278.25 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius Kabi USA, LLC | $99.40 | 1 | $0 (2017) |
| Melinta Therapeutics, LLC | $76.79 | 1 | $0 (2024) |
| BioDelivery Sciences International, Inc. | $73.34 | 1 | $0 (2019) |
| BTG International, Inc. | $16.92 | 1 | $0 (2021) |
| Merck Sharp & Dohme LLC | $11.80 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $76.79 | 1 | Melinta Therapeutics, LLC ($76.79) |
| 2022 | $11.80 | 1 | Merck Sharp & Dohme LLC ($11.80) |
| 2021 | $16.92 | 1 | BTG International, Inc. ($16.92) |
| 2019 | $73.34 | 1 | BioDelivery Sciences International, Inc. ($73.34) |
| 2017 | $99.40 | 1 | Fresenius Kabi USA, LLC ($99.40) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/23/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug) | Food and Beverage | In-kind items and services | $76.79 | General |
| Category: ANTIFUNGALS | ||||||
| 03/09/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/03/2021 | BTG International, Inc. | VORAXAZE (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Toxicity Antidote (Methotrexate Toxicity) | ||||||
| 08/21/2019 | BioDelivery Sciences International, Inc. | BELBUCA (Drug) | Food and Beverage | In-kind items and services | $73.34 | General |
| Category: Addiction Therapy | ||||||
| 08/24/2017 | Fresenius Kabi USA, LLC | Smoflipid (Drug) | Food and Beverage | In-kind items and services | $99.40 | General |
| Category: Nutrition | ||||||
About Richard Wheeler, PHARM D
Richard Wheeler, PHARM D is a Clinical Pharmacology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2017. The National Provider Identifier (NPI) number assigned to this provider is 1396254082.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Richard Wheeler, PHARM D has received a total of $278.25 in payments from pharmaceutical and medical device companies, with $76.79 received in 2024. These payments were reported across 5 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($278.25).
Practice Information
- Specialty Clinical Pharmacology
- Location Oklahoma City, OK
- Active Since 09/25/2017
- Last Updated 07/21/2022
- Taxonomy Code 208U00000X
- Entity Type Individual
- NPI Number 1396254082
Products in Payments
- Smoflipid (Drug) $99.40
- Rezzayo (Drug) $76.79
- BELBUCA (Drug) $73.34
- VORAXAZE (Drug) $16.92
- DIFICID (Drug) $11.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.